Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1.
Xuesen LiLiankun SongShan XuMatthew TippinShuan MengJun XieEdward UchioXiaolin Zi
Published in: Journal of translational genetics and genomics (2021)
Our results suggest that consumption of kava products through diet can delay prostate cancer development and progression and that kavalactones may be a new structure model for developing a potent dual inhibitor of LSD1 and MAO-A.